We hypothesized that targeting of β1 integrin/FN interaction in combination with ER blockade could be an effective strategy to avoid emergence of FN-induced Tam resistance and the selection of breast cancer stem cells—events associated with cancer recurrence. This evidence concerns the gene ESR1 and cancer.